Parenteral Drugs (India) Limited (PDPL.NS)
- Previous Close
2.9000 - Open
2.7000 - Bid --
- Ask --
- Day's Range
2.7000 - 2.9000 - 52 Week Range
2.7000 - 3.4000 - Volume
1,063 - Avg. Volume
0 - Market Cap (intraday)
101.077M - Beta (5Y Monthly) 0.18
- PE Ratio (TTM)
-- - EPS (TTM)
-25.6100 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date Sep 13, 2010
- 1y Target Est
--
Parenteral Drugs (India) Limited operates as a healthcare company in India. The company manufactures pharmaceutical products, including intravenous infusion, inhalation, veterinary infusion, etc. It also offers IV fluids, such as carbohydrates and electrolytes, diuretics, dialysis and irrigation solutions, anti-infective and anti-fungal products, and others; and oncology and anaesthesia products. The company also exports its products to Iraq, Yemen, Mozambique, Ghana, Kenya, Kyrgyzstan, Uzbekistan, Sudan, Vietnam, Cambodia, Liberia, Sri Lanka, Nepal, Myanmar, and Cameroon. The company was incorporated in 1983 and is based in Indore, India.
www.pdindia.com--
Full Time Employees
March 31
Fiscal Year Ends
Sector
Related News
Performance Overview: PDPL.NS
Trailing total returns as of 4/24/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: PDPL.NS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: PDPL.NS
Valuation Measures
Market Cap
101.08M
Enterprise Value
1.17B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.02
Price/Book (mrq)
--
Enterprise Value/Revenue
13.81
Enterprise Value/EBITDA
3.15
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-6.55%
Return on Equity (ttm)
--
Revenue (ttm)
84.96M
Net Income Avi to Common (ttm)
-763.62M
Diluted EPS (ttm)
-25.6100
Balance Sheet and Cash Flow
Total Cash (mrq)
1k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
5.26B
Company Insights: PDPL.NS
PDPL.NS does not have Company Insights